Human Holdings Co (2415) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
17 Aug, 2026Executive summary
Revenue/net sales increased 2.6% year-over-year to ¥26,295 million, driven by growth in education and nursing care segments.
Operating profit declined 5.9% year-over-year to ¥607 million, mainly due to staffing segment pressures.
Ordinary profit rose 13.9% to ¥890 million, supported by increased subsidies in nursing care.
Net profit attributable to shareholders/owners of parent grew 31.2% to ¥534 million.
Earnings per share increased to ¥51.46 from ¥39.23 in the prior year period.
Financial highlights
Gross profit rose to ¥6,710 million from ¥6,617 million year-over-year.
Selling, general and administrative expenses increased to ¥6,102 million from ¥5,971 million.
Non-operating income more than doubled to ¥312 million, driven by higher subsidy income.
Total assets: ¥52,156 million as of June 30, 2026.
Net assets/equity: ¥19,351 million as of June 30, 2026.
Segment performance
Staffing: Revenue up 0.5% to ¥15,454 million; operating profit down 14.6% to ¥781 million due to higher personnel investment and lower placement revenue.
Education: Revenue up 5.4% to ¥6,869 million; operating loss improved to ¥31 million, driven by strong adult and international education and improved gross margin in child education.
Nursing care: Revenue up 7.8% to ¥3,420 million; operating profit down 59.6% to ¥21 million due to higher personnel costs from wage improvements.
Other: Revenue down 0.9% to ¥548 million; operating profit up to ¥60 million, with sports business declining and nail business stable.
Latest events from Human Holdings Co
- Quarterly revenue and profits increased, with a dividend hike and growth forecast.2415
Q1 2025 - Revenue and profit rose year-over-year, with strong human resources growth and stable outlook.2415
Q2 2025 - Profits and sales rose, record outlook set, and shareholder returns were enhanced.2415
Q3 2025 - Record revenue and profit growth, improved margins, and higher dividends with steady outlook.2415
Q4 2025 - Revenue and profit increased across all segments, led by human resources and nursing care.2415
Q1 2026 - Revenue and profits grew strongly, with record full-year results and extraordinary gains expected.2415
Q2 2026 - Revenue up 1.9% YoY, but profits dipped; outlook and dividend forecast remain strong.2415
Q3 2026 - Revenue and operating profit rose, but net profit fell 15% on extraordinary losses.2415
Q4 2026